Papadatou Ioanna, Geropeppa Maria, Verrou Kleio-Maria, Tzanoudaki Marianna, Lagousi Theano, Liatsis Emmanouil, Spoulou Vana
First Department of Paediatrics, Medical School, "Aghia Sophia" Children's Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Immunobiology and Vaccinology Research Lab, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Vaccines (Basel). 2023 Jan 1;11(1):103. doi: 10.3390/vaccines11010103.
mRNA vaccines have played a crucial role in controlling the SARS-CoV-2 global pandemic. However, the immunological mechanisms involved in the induction, magnitude and longevity of mRNA-vaccine-induced protective immunity are still unclear.
In our study, we used whole-RNA sequencing along with detailed immunophenotyping of antigen-specific T cells and humoral RBD-specific response to dual immunization with the Pfizer-BioNTech mRNA vaccine (BNT162b2) and correlated them with response to an additional dose, administered 10 months later, in order to comprehensively profile the immune response of healthy volunteers to BNT162b2.
Primary dual immunization induced upregulation of the Type I interferon pathway and generated spike protein (S)-specific IFN-γ+ and TNF-α+ CD4 T cells, S-specific memory CD4 T cells, and RBD-specific antibodies against SARS-CoV-2. S-specific CD4 T cells induced by the primary series correlated with the RBD-specific antibody titers to a third dose.
This study demonstrates the induction of both innate and adaptive immunity in response to the BNT162b2 mRNA vaccine in a coordinated manner and identifies the central role of primarily induced CD4+ T cells as a predictive biomarker of the magnitude of anamnestic immune response.
mRNA疫苗在控制SARS-CoV-2全球大流行中发挥了关键作用。然而,mRNA疫苗诱导的保护性免疫的诱导、强度和持久性所涉及的免疫机制仍不清楚。
在我们的研究中,我们使用全RNA测序以及对抗原特异性T细胞的详细免疫表型分析和对辉瑞- BioNTech mRNA疫苗(BNT162b2)双重免疫的体液RBD特异性反应,并将它们与10个月后给予的额外一剂疫苗的反应相关联,以便全面描绘健康志愿者对BNT162b2的免疫反应。
初次双重免疫诱导了I型干扰素途径的上调,并产生了刺突蛋白(S)特异性IFN-γ+和TNF-α+ CD4 T细胞、S特异性记忆CD4 T细胞以及针对SARS-CoV-2的RBD特异性抗体。初次免疫系列诱导的S特异性CD4 T细胞与第三剂的RBD特异性抗体滴度相关。
本研究证明了对BNT162b2 mRNA疫苗以协调方式诱导先天性和适应性免疫,并确定了主要诱导的CD4+ T细胞作为回忆性免疫反应强度的预测生物标志物的核心作用。